Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer
Authors:
Open Access
- 1 June 2015
- journal article
- review article
- Published by Elsevier in Translational Oncology
- Vol. 8 (3) , 217-230
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Diffusion‐weighted magnetic resonance imaging in follow‐up of superficial urinary bladder carcinoma after transurethral resection: initial experienceBJU International, 2012
- ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder CancerPLOS ONE, 2011
- The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesionsBritish Journal of Radiology, 2011
- Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative StudyJournal of Urology, 2011
- Diffusion coefficient measurement using a temperature‐controlled fluid for quality control in multicenter studiesJournal of Magnetic Resonance Imaging, 2011
- Bony metastases: assessing response to therapy with whole-body diffusion MRICancer Imaging, 2011
- Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping and Spectroscopy in Prostate CancerTopics in Magnetic Resonance Imaging, 2008
- Evaluation of diffusion‐weighted imaging for the differential diagnosis of poorly contrast‐enhanced and T2‐prolonged bone masses: Initial experienceJournal of Magnetic Resonance Imaging, 2006
- Bladder cancer stagingBJU International, 2000